Virus News and Research

Latest Virus News and Research

Interdisciplinary project explores the phenomenon of so-called “superspreaders”

Scientists from the Departments of Physics, Biomedical Sciences and Process Engineering at Otto von Guericke University Magdeburg are in the process of analyzing the emergence and spread of infectious air bubbles in our breath, known as aerosols, using tissue cultivations and artificially-produced, virus-filled suspended particles.

3 May 2021

Study reveals new broadly neutralizing and protective antibody against coronaviruses

In the setting of potentially reduced vaccine efficacy against coronavirus disease (COVID-19) due to emerging viral variants, the deployment of effective treatments based on monoclonal antibodies may be an additional strategy to help control the pandemic. A new study by US researchers, currently available on the bioRxiv* preprint server, describes the action of a specific antibody known as DH1047.

3 May 2021

Researchers develop a nanoparticle-based formulation with anti-SARS-CoV-2 activity

A study recently published in the journal Matter has demonstrated the development and validation of a nanoparticle-based formulation, capable of completely inhibiting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection blocking the interaction between viral spike protein and host cell angiotensin-converting enzyme 2 (ACE2).

3 May 2021

Could CRISPR be used as a SARS-CoV-2 antiviral?

The potential of using this gene manipulation technology as a SARS-CoV-2 inhibitor or prophylactic is investigated in a review recently uploaded to the journal Experimental Biology and Medicine (April 25th, 2021) by Arnab Banerjee and colleagues.

2 May 2021

Study implies a likely rise of future SARS-CoV-2 recombinants

A recent astonishing feat by US researchers revealed that recombination is not only widespread in the evolutionary history of SARS-like coronaviruses, but it can also increase fitness traits of seasonal coronaviruses. Their paper is currently available on the bioRxiv* preprint server and sets the stage for phylogenetic tracking of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

2 May 2021

Live "attenuated" influenza virus vaccine protects animals against respiratory infections, including SARS-CoV-2

Researchers in the United States and Austria have demonstrated the potential of a modified influenza virus as a vaccine to protect against viral respiratory pathogens, including the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19).

2 May 2021

Previously infected vaccinees broadly neutralize SARS-CoV-2 variants of concern

Researchers in the United States have conducted a study demonstrating the effectiveness of first-generation vaccines at protecting against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals who have previously been infected with the virus.

2 May 2021

Antiviral T cells safe, effective as off-the-shelf therapy for painful complication after stem cell transplants

A Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center found that BK virus (BKV)-specific T cells from healthy donors were safe and effective as an off-the-shelf therapy for BKV-associated hemorrhagic cystitis (BKV-HC), a painful complication common after allogeneic stem cell transplants for patients with leukemia or lymphoma.

30 Apr 2021

New technology enables faster and more accurate tracing of COVID-19 and other viruses

Jeremy Edwards, director of the Computational Genomics and Technology (CGaT) Laboratory at The University of New Mexico, and his colleagues at Centrillion Technologies in Palo Alto, Calif. and West Virginia University, have developed a chip that provides a simpler and more rapid method of genome sequencing for viruses like COVID-19.

30 Apr 2021

Friendly gut bacteria emerged as an invaluable ally in the battle against malnutrition

Treating malnutrition by boosting gut microbes produces better results than traditional nutritional supplements.

30 Apr 2021

Single dose of vaccine boosts protection only in people previously infected by COVID-19

A single dose of vaccine boosts protection against SARS-CoV-2 coronavirus variants, but only in those with previous COVID-19, a study has found.

30 Apr 2021

Applications of nanoparticles in combating COVID-19

Researchers review the various properties and use of nanoparticles in targeting SARS-CoV-2 and how they could be used to develop new therapeutics and diagnostics for SARS-CoV-2.

30 Apr 2021

Furin cleavage site crucial in SARS-CoV-2 for viral transmission in ferrets, finds study

Researchers based at Imperial College London, UK, have recently highlighted the effects of these deleterious CS mutations through a ferret animal model, demonstrating that furin cleavage sites are a necessary component in the virus’ ability to replicate.

30 Apr 2021

Despite all the talk, Covid vaccination does not infect people with shingles

Posts are showing up all over social media tying Covid-19 vaccinations to shingles and other painful skin disorders.

30 Apr 2021

Vaccine hesitancy is not a barrier to vaccination efforts, says study

A team of researchers from the USA, Germany and Norway recently found that the main barrier to vaccination is not vaccine hesitancy but a supply shortage and unequal distribution of the vaccines themselves.

30 Apr 2021

The vulnerable homebound are left behind on vaccination

It was April, more than three months into the vaccination campaign against covid-19, and Jim Freeman, 83, still had not gotten his first dose.

30 Apr 2021

Hepatitis C antivirals synergize with remdesivir to inhibit SARS-CoV-2 in vitro

A new study sheds light on the potential of drug combinations to stem viral transmission and treat patients with COVID-19. It also shows that four drugs used to treat hepatitis C synergize with remdesivir to make it up to ten times more effective at inhibiting SARS-CoV-2 in cell cultures.

30 Apr 2021

Could portable air filters promote clearance of SARS-CoV-2-contaminated aerosols indoors?

A new study shows that inexpensive portable air cleaners may boost the removal of aerosols containing the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from indoor spaces by as much as three times, compared to conventional Heating, Ventilation, and Air Conditioning (HVAC) systems.

30 Apr 2021

Could COVID-19 rapid antigen tests aid international border control measures?

A recent study has explored the use of rapid antigen testing for COVID-19 at borders to reduce community transmission, and concluded that it would be effective only at lower volumes of passenger traffic.

30 Apr 2021

Study develops COVID-19 pandemic reopening strategies in California

A working paper from researchers at the RAND corporation explores the various options to come up with a proposed robust plan for reopening up regions where vaccines have not yet been deployed across the entire population.

30 Apr 2021

Virus News and Research

Latest Virus News and Research

Interdisciplinary project explores the phenomenon of so-called “superspreaders”

Study reveals new broadly neutralizing and protective antibody against coronaviruses

Researchers develop a nanoparticle-based formulation with anti-SARS-CoV-2 activity

Could CRISPR be used as a SARS-CoV-2 antiviral?

Study implies a likely rise of future SARS-CoV-2 recombinants

Live "attenuated" influenza virus vaccine protects animals against respiratory infections, including SARS-CoV-2

Previously infected vaccinees broadly neutralize SARS-CoV-2 variants of concern

Antiviral T cells safe, effective as off-the-shelf therapy for painful complication after stem cell transplants

New technology enables faster and more accurate tracing of COVID-19 and other viruses

Friendly gut bacteria emerged as an invaluable ally in the battle against malnutrition

Single dose of vaccine boosts protection only in people previously infected by COVID-19

Applications of nanoparticles in combating COVID-19

Furin cleavage site crucial in SARS-CoV-2 for viral transmission in ferrets, finds study

Despite all the talk, Covid vaccination does not infect people with shingles

Vaccine hesitancy is not a barrier to vaccination efforts, says study

The vulnerable homebound are left behind on vaccination

Hepatitis C antivirals synergize with remdesivir to inhibit SARS-CoV-2 in vitro

Could portable air filters promote clearance of SARS-CoV-2-contaminated aerosols indoors?

Could COVID-19 rapid antigen tests aid international border control measures?

Study develops COVID-19 pandemic reopening strategies in California

A new way of characterising biomolecules eBook

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in